Evidence map›Paper›PMID 42232630›Full record

ArticleFrontiers in pediatrics2026

The very rare association between T-cell acute lymphoblastic leukemia and down syndrome: a case report and review of the literature.

Giacomo Gotti, Laura Rachele Bettini, Stefano Rebellato, Valentino Conter, Antonella Colombini, Veronica Leoni, Alessandra Sala, Marco Spinelli, Andrea Biondi, Grazia Fazio and 2 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Giacomo GottiPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Laura Rachele BettiniPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Stefano RebellatoTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Valentino ConterTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Antonella ColombiniPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Veronica LeoniPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Alessandra SalaPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Marco SpinelliPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Andrea BiondiTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Grazia FazioSchool of Medicine and Surgery, University Milano-Bicocca, Monza, Italy.
Adriana Cristina BalduzziPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Carmelo RizzariPediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Children with Down syndrome (DS) show a higher incidence of acute lymphoblastic leukemia (ALL) compared to general population. They are almost entirely affected by B-cell precursor ALL, linked to the constitutional chromosome 21 trisomy and associated with recurrent mutational patterns. The occurrence of T-cell ALL (T-ALL) is extremely rare in DS patients, with only few reports described. This entity remains poorly characterized either genetically and clinically, and there are no standardized guidelines for the treatment of these rare and fragile patients. Here we describe the case of a child with DS and T-ALL and provide comprehensive genetic characterization of his disease. Case report: A previously well 7-year-old boy with DS was diagnosed with T-ALL presenting with leukocytosis, mediastinal mass and central nervous system involvement (CNS2). Genetic studies showed a complex karyotype with the translocation t(1;14)(p32;q11) and deletion of chromosome 9p. RNA sequencing was negative for fusion transcript. Next-generation sequencing analysis for somatic mutations on DNA material showed pathogenic variants in Conclusion: This case provides the first detailed genetic characterization of T-ALL in a child with DS. The findings of typical T-ALL somatic mutations and genetic alterations suggest a sporadic leukemogenesis origin, distinct from the specific pathway associated with B-cell precursor ALL. We confirm the rarity of this entity and the extreme susceptibility to treatment complications. An improved knowledge and characterization of DS T-ALL might be helpful to inform clinicians about treatment decision making for this very rare disease.

Indexed as

acute lymphoblastic leukemiadown syndromegenetic characterizationT-cell acute lymphoblastic leukemiatreatment strategy

Identifiers

PMID42232630
PMCPMC13223181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.